STAT3 and cancer: Zhang et al. [41] demonstrated that PTPRT negatively regulates STAT3-mediated signaling by directly dephosphorylating STAT3 at Y705, which prohibits STAT3 nuclear translocation, resulting in a variety of effects depending on the cancer type.